Related Experiment Video

Updated: Jun 19, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Hypersomnia in children: interface with psychiatric disorders

Suresh Kotagal1

  • 1Department of Neurology, Division of Child Neurology, The Center for Sleep Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. kotagal.suresh@mayo.edu

Child and Adolescent Psychiatric Clinics of North America
|October 20, 2009
PubMed

Insights

Daytime sleepiness in children can signal underlying mood or behavioral issues, while hypersomnia may present with psychiatric symptoms. Addressing sleep disorders improves alertness and quality of life in pediatric patients.

Area of Science:

  • Pediatric Psychiatry
  • Sleep Medicine
  • Child Psychology

Background:

  • Daytime sleepiness is common in pediatric patients with behavior and mood disturbances.
  • Conversely, hypersomnia patients may exhibit mood or behavioral issues.
  • The overlap suggests a complex relationship between sleep and psychiatric conditions in youth.

Purpose of the Study:

  • To explore the diverse etiologies of daytime sleepiness in children and adolescents.
  • To highlight the connection between sleep disorders and psychiatric symptoms.
  • To emphasize the importance of considering sleep issues in psychiatric evaluations.

Main Methods:

  • Literature review of pediatric sleep and psychiatric disorders.
  • Analysis of patient presentations in child psychiatry and sleep clinics.
  • Synthesis of etiological factors for daytime sleepiness.

Main Results:

  • Diverse causes of daytime sleepiness include poor sleep hygiene, sleep apnea, delayed sleep phase syndrome, idiopathic hypersomnia, periodic hypersomnia, narcolepsy, and mood disorders.
  • Psychiatric symptoms can be presenting features of underlying sleep disorders.
  • Effective treatment of sleep disorders positively impacts alertness and quality of life.

Conclusions:

  • A high index of suspicion for sleep problems is crucial in children and adolescents with psychiatric disorders.
  • Integrated approaches to diagnosing and treating both sleep and psychiatric conditions are beneficial.
  • Recognizing the bidirectional relationship improves patient outcomes.

More Related Videos

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...